Recomienda este artículo a tus amigos:
Intracellular Delivery III: Market Entry Barriers of Nanomedicines - Fundamental Biomedical Technologies Softcover Reprint of the Original 1st 2016 edition
Intracellular Delivery III: Market Entry Barriers of Nanomedicines - Fundamental Biomedical Technologies
It can be argued that drugs generated using the conventional means of drug development (i.e., relying on facile biodistribution and activity after (preferably) oral administration) are not suitable for a target-specific delivery and would not benefit from such delivery even when a seemingly perfect delivery system is available.
453 pages, 65 Illustrations, color; 16 Illustrations, black and white; XIII, 453 p. 81 illus., 65 il
| Medios de comunicación | Libros Paperback Book (Libro con tapa blanda y lomo encolado) |
| Publicado | 12 de julio de 2018 |
| ISBN13 | 9783319828466 |
| Editores | Springer International Publishing AG |
| Páginas | 453 |
| Dimensiones | 150 × 220 × 10 mm · 789 g |
| Lengua | Alemán |
| Editor | Prokop, Ales |
| Editor | Weissig, Volkmar |